Background
Methods
Setting and definitions
Microbiological methods
Statistical analysis
Results
Variables | Controls | Cases | Total | P value | |||
---|---|---|---|---|---|---|---|
N = 90 (66.6%) | N = 45 (33.4%) | N = 135 | |||||
N | % | N | % | N | % | ||
Age (years), Mean ± SD (range) | 76 ± 15 (18–94) | 75 ± 16 (18–95) | 75.7 ± 16 (18–95) | 0.769 | |||
Male, sex | 59 | 65.6 | 26 | 57.8 | 85 | 63 | 0.378 |
LOS, mean ± SD (range) | 26.8 ± 23.3 (3–127) | 48.7 ± 34.0 (7–159) | 34.1 ± 29.1 (3–159) | < 0.001 | |||
ICU stay | 18 | 20 | 20 | 44.4 | 38 | 28.1 | 0.003 |
aDeaths | 1 | 2.9 | 5 | 29.4 | 6 | 11.8 | 0.006 |
Provenance of patient at admission | |||||||
Home | 83 | 92.2 | 36 | 80.0 | 119 | 88.2 | 0.003 |
LTHCF | 1 | 1.1 | 7 | 15.6 | 8 | 5.9 | |
Other hospital | 6 | 6.7 | 2 | 4.4 | 8 | 5.9 | |
bRecent hospitalization | 6 | 6.7 | 8 | 17.8 | 14 | 10.4 | 0.046 |
Charlson Comorbidity Index, Mean ± SD (range) | 5.9 ± 2.5 (0–12) | 6.9 ± 2.7 (0–12) | 6.3 ± 2.6(0–12) | 0.050 | |||
McCabe score | |||||||
Nonfatal disease | 54 | 60.0 | 20 | 44.4 | 74 | 54.8 | 0.019 |
Fatal disease (within 5 years) | 36 | 40.0 | 22 | 48.9 | 58 | 43.0 | |
Rapidly fatal disease (within 6 months) | 0 | 0.0 | 3 | 6.7 | 3 | 2.2 | |
Major surgery ≤ 30 days before hospitalization | 3 | 3.3 | 2 | 4.4 | 5 | 3.7 | 0.747 |
Major surgery during hospitalization | 20 | 22.2 | 15 | 33.3 | 35 | 25.9 | 0.165 |
Diagnosis at hospital admission | |||||||
Infection | 54 | 60.0 | 32 | 71.1 | 86 | 63.7 | 0.115 |
Polytrauma | 17 | 18.9 | 2 | 4.4 | 19 | 14.1 | |
Cardiovascular disease | 15 | 16.7 | 10 | 22.2 | 25 | 18.5 | |
Cancer | 4 | 4.4 | 1 | 2.2 | 5 | 3.7 | |
Presence of intrinsic risk factors and comorbidities | |||||||
Chronic heart failure | 48 | 53.3 | 28 | 62.2 | 76 | 56.3 | 0.326 |
Hypertension | 57 | 63.3 | 29 | 64.4 | 86 | 63.7 | 0.899 |
Peripheral vascular disease | 22 | 24.4 | 20 | 44.4 | 42 | 31.1 | 0.018 |
Stroke or TIA | 27 | 30.0 | 18 | 40.0 | 45 | 33.3 | 0.245 |
Dementia | 22 | 24.4 | 18 | 40.0 | 40 | 29.6 | 0.062 |
COPD | 16 | 17.8 | 10 | 22.2 | 26 | 19.3 | 0.537 |
Chronic hepatitis | 8 | 8.9 | 3 | 6.7 | 11 | 8.1 | 0.656 |
Gastrointestinal disease | 36 | 40.0 | 12 | 26.7 | 48 | 35.6 | 0.127 |
Solid neoplasia & haematological neoplasia | 28 | 31.1 | 15 | 33.3 | 43 | 31.8 | 0.693 |
CKD | 33 | 36.7 | 13 | 28.9 | 46 | 34.1 | 0.369 |
Diabetes mellitus | 22 | 24.4 | 15 | 33.3 | 37 | 27.4 | 0.275 |
Disability | 0.0 | 0.0 | 0 | ||||
No disability | 68 | 75.6 | 22 | 48.9 | 90 | 66.7 | 0.003 |
Partial | 15 | 16.7 | 11 | 24.4 | 26 | 19.3 | |
Bedridden | 7 | 7.8 | 12 | 26.7 | 19 | 14.1 | |
Permanent devices | 6 | 6.7 | 11 | 24.4 | 17 | 12.6 | 0.003 |
Presence of extrinsic risk factors | |||||||
Central vascular catheterization | 7 | 7.8 | 21 | 46.7 | 28 | 20.7 | < 0.001 |
PICC or midline | 6 | 6.7 | 11 | 24.4 | 17 | 12.6 | 0.003 |
Urinary catheter | 38 | 42.2 | 37 | 82.2 | 75 | 55.6 | < 0.001 |
Naso-gastric tube | 8 | 8.9 | 13 | 28.9 | 21 | 15.6 | 0.003 |
PEG | 1 | 1.1 | 5 | 11.1 | 6 | 4.4 | 0.008 |
Tracheostomy | 3 | 3.3 | 12 | 26.7 | 15 | 11.1 | < 0.001 |
Mechanical ventilation | 7 | 7.8 | 10 | 22.2 | 17 | 12.6 | 0.017 |
Dialysis | 3 | 3.3 | 3 | 6.7 | 6 | 4.4 | 0.376 |
Blood transfusion | 24 | 26.7 | 11 | 24.4 | 35 | 25.9 | 0.781 |
Antibiotics ≤ 30 days before hospitalization | 9 | 10.0 | 9 | 20.0 | 18 | 13.3 | 0.113 |
Chemotherapy | 3 | 3.3 | 6 | 13.3 | 9 | 6.7 | 0.028 |
Corticosteroid therapy | 15 | 16.7 | 16 | 35.6 | 31 | 23 | 0.014 |
cAntibiotics during hospitalization | 65 | 72.2 | 43 | 95.6 | 108 | 80 | 0.001 |
3GC | 26 | 28.9 | 20 | 44.4 | 46 | 34.1 | 0.087 |
Carbapenems | 5 | 5.6 | 13 | 28.9 | 18 | 13.3 | < 0.001 |
Penicillins | 47 | 52.2 | 31 | 68.9 | 78 | 57.8 | 0.086 |
Fluoroquinolones | 13 | 14.4 | 12 | 26.7 | 25 | 18.5 | 0.097 |
Glycopeptides | 11 | 12.2 | 15 | 33.3 | 26 | 19.3 | 0.004 |
dPolytherapy | 22 | 24.4 | 26 | 57.8 | 48 | 35.6 | < 0.001 |
Number of antibiotics used in the hospitalization, mean ± SD (range) | 1.53 ± 1.44 (0–5) | 3.64 ± 2.69 (0–13) | 2.24 ± 2.19 (0–13) | < 0.001 |
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Age (years) | 0.99 | 0.97–1.01 | 0.767 | |||
Sex, male | 0.71 | 0.34–1.49 | 0.378 | |||
LOS | 1.02 | 1.01–1.04 | < 0.001 | 1.03 | 1.01–1.05 | 0.002 |
ICU stay | 3.2 | 1.46–6.99 | 0.004 | |||
aDeaths | 5.5 | 1.77–17.01 | 0.003 | |||
Provenance of patient at admission | ||||||
Home | Ref. | |||||
LTHCF | 16.14 | 1.91–136 | 0.011 | |||
Other hospital | 0.76 | 0.14–3.99 | 0.754 | |||
Recent hospitalization | 3.02 | 0.98–9.34 | 0.054 | |||
Charlson Comorbidity Index | 1.15 | 0.99–1.33 | 0.053 | |||
McCabe score, nonfatal vs. fatal disease and rapidly fatal disease | 2.12 | 1.08–4.14 | 0.027 | 5.45 | 1.87–15.89 | 0.002 |
Major surgery ≤ 30 days before hospitalization | 1.34 | 0.21–8.37 | 0.748 | |||
Major surgery during hospitalization | 1.75 | 0.79–3.87 | 0.167 | |||
Diagnosis at hospital admission | ||||||
Infection | ref | |||||
Polytrauma | 0.19 | 0.04–0.91 | 0.038 | |||
Cardiovascular disease | 1.12 | 0.45–2.79 | 0.800 | |||
Cancer | 0.42 | 0.0.4–3.94 | 0.449 | |||
Presence of intrinsic risk factors and comorbidity | ||||||
Chronic heart failure | 1.44 | 0.69–2.99 | 0.327 | |||
Hypertension | 1.04 | 0.49–2.21 | 0.899 | |||
Peripheral vascular disease | 2.47 | 1.15–5.28 | 0.019 | |||
Stroke or TIA | 1.55 | 0.73–3.28 | 0.247 | |||
Dementia | 2.06 | 0.95–4.43 | 0.064 | |||
COPD | 1.32 | 0.54–3.20 | 0.538 | |||
Chronic hepatitis, cirrhosis | 0.73 | 0.18–2.90 | 0.657 | |||
Gastrointestinal disease | 0.54 | 0.24–1.19 | 0.130 | |||
Solid neoplasia | 1.10 | 0.51–2.37 | 0.794 | |||
CKD | 0.70 | 0.32–1.52 | 0.370 | |||
Diabetes mellitus | 1.54 | 0.70–3.38 | 0.277 | |||
Disability | ||||||
No disability | ref | |||||
Partial | 2.26 | 0.90–5.65 | 0.79 | |||
Bedridden | 5.29 | 1.85–15.12 | 0.002 | |||
Permanent devices | 4.52 | 1.55–13.22 | 0.006 | 10.15 | 2.27–45.39 | 0.002 |
Presence of extrinsic risk factors | ||||||
Central vascular catheterization | 10.37 | 3.93–27.32 | < 0.001 | |||
PICC or midline | 4.52 | 1.55–13.22 | 0.006 | |||
Urinary catheter | 7.23 | 2.91–17.96 | < 0.001 | 4.96 | 1.52–16.19 | 0.008 |
Naso-gastric tube | 4.16 | 1.57–10.99 | 0.004 | |||
PEG | 11.12 | 1.25–98–33 | 0.030 | |||
Tracheostomy | 10.54 | 2.79–39.75 | 0.001 | |||
Mechanical ventilation | 3.38 | 1.19–9.61 | 0.022 | 40.01 | 4.05–395.1 | 0.002 |
Dialysis | 2.07 | 0.40–10.70 | 0.385 | |||
Blood transfusion | 0.88 | 0.38–2.03 | 0.781 | |||
Antibiotics ≤ 30 days before hospitalization | 2.22 | 0.81–6.06 | 0.119 | |||
Chemotherapy | 4.46 | 1.06–18.76 | 0.041 | |||
Corticosteroid therapy | 2.75 | 1.20–6.29 | 0.016 | |||
Antibiotics during hospitalization | 8.26 | 1.86–36–72 | 0.005 | |||
3GC | 1.90 | 0.90–4.01 | 0.089 | |||
Carbapenems | 6.66 | 2.19–20.20 | 0.001 | 5.39 | 1.14–25.44 | 0.033 |
Penicillins | 1.93 | 0.90–4.11 | 0.088 | |||
Fluoroquinolones | 2.09 | 0.86–5.08 | 0.101 | |||
Glycopeptides | 3.5 | 1.44–8.48 | 0.006 | |||
Polytherapy | 4.65 | 2.13–10.14 | < 0.001 | |||
Number of antibiotics used in the hospitalization, mean ± SD (range) | 1.73 | 1.36–2.19 | < 0.001 |
Subgroup analysis by department
Variables | Geriatrics n = 51 | Internal medicine = 51 | ICU n = 21 | ||||||
---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Univariate analysis | Univariate analysis | |||||||
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
Age (years) | 0.99 | 0.91–1.08 | 0.896 | 0.99 | 0.95–1.04 | 0.861 | 0.99 | 0.95–1.03 | 0.843 |
Sex, male | 0.77 | 0.23–2.57 | 0.682 | 0.49 | 0.15–1.59 | 0.237 | 1 | 0.07–13.36 | 1.000 |
LOS | 1.01* | 0.99–1.03 | 0.082 | 1.02* | 1.00–1.05 | 0.012 | 1.03 | 0.99–1.07 | 0.134 |
ICU stay | 7.07 | 0.67–73.99 | 0.103 | 6.52 | 1.70–25.03 | 0.006 | 2.4 | 0.21–26.82 | 0.477 |
aDeaths | 13.75 | 1.45–129.98 | 0.022 | 1 | 0.08–11.87 | 1.000 | 8 | 0.96–66.44 | 0.054 |
Provenance of patient at admission | |||||||||
Home | ref. | ref. | ref. | ||||||
LTHCF | – | 4.46 | 0.37–53.70 | 0.239 | – | ||||
Other hospital | – | 1.11 | 0.18–6.87 | 0.906 | – | ||||
Recent hospitalization | 1 | 0.08–11.87 | 1.000 | 3.17 | 0.62–16.24 | 0.165 | 9.75 | 0.78–121.83 | 0.077 |
Charlson index | 1.15 | 0.84–1.57 | 0.358 | 1.21 | 0.95–1.55 | 0.113 | 1.18 | 0.83–1.67 | 0.335 |
McCabe Score, Nonfatal vs. fatal disease and rapidly fatal disease | 2.69* | 0.80–8.93 | 0.107 | 0.76 | 0.21–2.68 | 0.675 | 8.38 | 1.16–60.45 | 0.035 |
Major surgery during hospitalization | 0.69 | 0.15–3.05 | 0.631 | 4.30 | 0.88–20.87 | 0.070 | 4.49 | 0.54–37.37 | 0.164 |
Disability | |||||||||
No disability | ref. | ref. | ref. | ||||||
Partial | 2.18 | 0.51–9.22 | 1.93 | 0.38–9.72 | 0.424 | 11 | 0.81–147.86 | 0.070 | |
Bedridden | 4.19 | 0.94–18–70 | 1 | – | 1.83 | 0.12–27.79 | |||
Permanent devices | 5.63* | 1.19–26.48 | 0.028 | 1 | – | ||||
Presence of extrinsic risk factors | |||||||||
Central vascular catheterization | 6.66 | 1.13–39.09 | 0.036 | 18 | 3.23–100.21 | 0.001 | 1 | – | |
PICC or midline | 1 | – | 1.60 | 0.31–8.16 | 0.567 | 4.49 | 0.54–37.37 | 0.164 | |
Urinary catheter | 10.71* | 2.10–54.45 | 0.004 | 13.75 | 2.68–70.49 | 0.002 | 2.4 | 0.21–26.82 | 0.477 |
Naso-gastric tube | 10.15 | 1.03–99.60 | 0.047 | 4.92 | 0.80–30.25 | 0.085 | 6.25 | 0.83–46.56 | 0.074 |
Mechanical ventilation | 1 | 0.08–11.87 | 1.000 | 13.75 | 1.45–129.98 | 0.022 | 3.33 | 0.50–22.14 | 0.213 |
Antibiotics ≤ 30 days before hospitalization | 3.02 | 0.68–13.22 | 0.142 | 1.37 | 0.20–9.14 | 0.740 | 2.4 | 0.26–22.10 | 0.440 |
Chemotherapy | 2.13 | 0.27–16.63 | 0.470 | 4.39 | 0.36–52.37 | 0.241 | 1 | – | |
Corticosteroid therapy | 3.26 | 0.88–12.08 | 0.076 | 1.60 | 0.31–8.16 | 0.567 | 6.25 | 0.83–46.56 | 0.074 |
Antibiotics during hospitalization | 2.75 | 0.29–25.70 | 0.373 | 12.63* | 1.50–106.36 | 0.020 | 1 | – | |
3GC | 1.19 | 0.37–3.85 | 0.765 | 1 | 0.21–4.60 | 1.00 | 32.9 | 2.45–443.59 | 0.008 |
Carbapenems | 3.32 | 0.49–22.14 | 0.215 | 8.72 | 153–49.75 | 0.015 | 14.66 | 1.16–185.23 | 0.038 |
Penicillins | 0.77 | 0.23–2.57 | 0.682 | 4.64 | 1.24–17.24 | 0.022 | 1.2 | 0.08–16.23 | 0.891 |
Fluoroquinolones | 1.71 | 0.39–7.49 | 0.468 | 3.17 | 0.62–16.24 | 0.165 | 1.2 | 0.18–7.77 | 0.848 |
Glycopeptides | 4.06 | 1.04–15.72 | 0.043 | 2.13 | 0.27–16.63 | 0.470 | 7.5 | 0.92–61.04 | 0.060 |
Polytherapy | 2.68 | 0.79–9.11 | 0.113 | 7.45 | 1.89–29.34 | 0.004 | 1 | – | |
Number of antibiotics used in the hospitalization, mean ± SD (range) | 1.42 | 0.98–2.04 | 0.057 | 1.98 | 1.28–3.05 | 0.002 | 3.01 | 0.93–9.73 | 0.065 |